NEW YORK --(BUSINESS WIRE)--Oct. 18, 2018-- Medidata (NASDAQ:MDSO) today announced its financial results for the third quarter of 2018. “Our strong financial and operational performance this quarter highlight the momentum and success we are seeing in the market,” said Tarek Sherif , chairman and
NEW YORK --(BUSINESS WIRE)--Oct. 17, 2018-- Medidata (NASDAQ:MDSO) today announced that it will hold its Investor Day on October 24, 2018 in New York . The event will be webcast live from 8:30 a.m. to 10:30 a.m. and again at 1:30 p.m. to end at 3 p.m. ET at http://investor.mdsol.com .
Study to benchmark heart dimension and function based on diversity News summary: Results of World Alliance of Societies of Echocardiography (WASE) Normal Values Study will change standard of care for cardiovascular paradigms Medidata Cloud unifies imaging data across the study process, improving
Medidata Enables Digital Transformation in Life Sciences with Largest Data Repository, Powered by AI and Advanced Analytics News Summary Industry adoption leads to rapid growth of the Medidata Cloud, now with over 15,000 studies worldwide, spanning all clinical phases and therapeutic areas Over
NEW YORK --(BUSINESS WIRE)--Oct. 4, 2018-- Medidata (NASDAQ: MDSO) today announced that it will release its third quarter 2018 financial results before the market opens on Thursday, October 18, 2018 . The company will also hold a conference call at 8 a.m.
Decibel to Unify Data and Scale with Medidata Cloud News summary: Boston biotech company selects Medidata Cloud to unify clinical trial data Decibel adopts Medidata ePRO/eCOA and eTMF to rapidly scale and expand research Medidata Cloud to support clinical development for hearing loss, tinnitus, and
Company pride highest rated in survey Life science technology leader is Great Place to Work-Certified ™ Medidata scored high in workforce diversity, work life balance and culture Ranking based on anonymous votes from company employees NEW YORK --(BUSINESS WIRE)--Sep.
NEW YORK --(BUSINESS WIRE)--Aug. 28, 2018-- Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences. Rouven Bergmann , chief financial officer, will present at the Citi 2018 Global Technology Conference on Wednesday, Sept. 5, 2018 , in New York at 12:45 p.m.
Leading R&D focused Korean pharmaceutical company expands use of Intelligent Platform for Life Sciences Adds Edge Central Monitoring with Machine Learning and Rave eCOA/ePRO Hanmi streamlines management of clinical trial risk and mobile patient data Full Story SEOUL, South Korea --(BUSINESS
Company Named Top Global Performer for Second Year in a Row Ranking reinforces company’s position as a market leader in life sciences Customers and partners recognize Medidata’s value in accelerating their digital transformation Company unifies clinical development and empowers better decision